[
  {
    "ts": "2025-11-28T09:06:00+00:00",
    "headline": "North America Nucleic Acid Amplification Testing Market Analysis Report 2025-2033 - Technological Advances, Rising Diagnostic Demand, and Widespread Applications",
    "summary": "The North American Nucleic Acid Amplification Testing (NAAT) market will reach $7.64 billion by 2033, growing from $3.28 billion in 2024 with a CAGR of 9.87%. Driven by technological advances, rising diagnostic demand, and widespread applications, NAAT proves critical in identifying infectious diseases and genetic mutations. Notably, innovation, automation, and government support bolster the market's expansion. Despite regulatory hurdles and high costs, ongoing collaborations aim to enhance affo",
    "url": "https://finance.yahoo.com/news/north-america-nucleic-acid-amplification-090600176.html",
    "source": "GlobeNewswire",
    "provider": "yfinance",
    "raw": {
      "id": "ee745ebc-0305-3ba8-b9ad-a804bf9d0877",
      "content": {
        "id": "ee745ebc-0305-3ba8-b9ad-a804bf9d0877",
        "contentType": "STORY",
        "title": "North America Nucleic Acid Amplification Testing Market Analysis Report 2025-2033 - Technological Advances, Rising Diagnostic Demand, and Widespread Applications",
        "description": "",
        "summary": "The North American Nucleic Acid Amplification Testing (NAAT) market will reach $7.64 billion by 2033, growing from $3.28 billion in 2024 with a CAGR of 9.87%. Driven by technological advances, rising diagnostic demand, and widespread applications, NAAT proves critical in identifying infectious diseases and genetic mutations. Notably, innovation, automation, and government support bolster the market's expansion. Despite regulatory hurdles and high costs, ongoing collaborations aim to enhance affo",
        "pubDate": "2025-11-28T09:06:00Z",
        "displayTime": "2025-11-28T09:06:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/globenewswire.com/5eb8fb4faf1c060f50f5df5d2d6a527f",
          "originalWidth": 600,
          "originalHeight": 400,
          "caption": "North American Nucleic Acid Amplification Testing Market",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/NjRb7kn926PN8Yjd8Vpreg--~B/aD00MDA7dz02MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/5eb8fb4faf1c060f50f5df5d2d6a527f.cf.webp",
              "width": 600,
              "height": 400,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/1GpMj3joojguClrXBmHbOw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/5eb8fb4faf1c060f50f5df5d2d6a527f.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "GlobeNewswire",
          "url": "https://www.globenewswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/north-america-nucleic-acid-amplification-090600176.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/north-america-nucleic-acid-amplification-090600176.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "RHHBF"
            },
            {
              "symbol": "BDX"
            },
            {
              "symbol": "DHR"
            },
            {
              "symbol": "ABT"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-28T09:04:00+00:00",
    "headline": "North America Heart Pump Device Market Forecast and Company Analysis Report 2025-2033 Featuring Abbott, Getinge, Teleflex, Fresenius, LivaNova, CorWave, JARVIK HEART, ABIOMED",
    "summary": "The North America Heart Pump Device market is projected to grow from USD 2.92 billion in 2024 to USD 8.1 billion by 2033, reflecting a CAGR of 12% between 2025-2033. Key drivers include technological advancements, increasing heart disease prevalence, and a rising geriatric population. Devices like LVADs and total artificial hearts are crucial in treating advanced heart failure. The U.S. leads with a well-funded healthcare system, while Canada's universal healthcare supports access. Challenges in",
    "url": "https://finance.yahoo.com/news/north-america-heart-pump-device-090400009.html",
    "source": "GlobeNewswire",
    "provider": "yfinance",
    "raw": {
      "id": "d5fee944-6e2e-3da9-9273-2c74016e9788",
      "content": {
        "id": "d5fee944-6e2e-3da9-9273-2c74016e9788",
        "contentType": "STORY",
        "title": "North America Heart Pump Device Market Forecast and Company Analysis Report 2025-2033 Featuring Abbott, Getinge, Teleflex, Fresenius, LivaNova, CorWave, JARVIK HEART, ABIOMED",
        "description": "",
        "summary": "The North America Heart Pump Device market is projected to grow from USD 2.92 billion in 2024 to USD 8.1 billion by 2033, reflecting a CAGR of 12% between 2025-2033. Key drivers include technological advancements, increasing heart disease prevalence, and a rising geriatric population. Devices like LVADs and total artificial hearts are crucial in treating advanced heart failure. The U.S. leads with a well-funded healthcare system, while Canada's universal healthcare supports access. Challenges in",
        "pubDate": "2025-11-28T09:04:00Z",
        "displayTime": "2025-11-28T09:04:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/globenewswire.com/6c24f9e1d809ad15320a801b2524cb1e",
          "originalWidth": 600,
          "originalHeight": 400,
          "caption": "North American Heart Pump Device Market",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/_CZ5J7eAFgg9_WN0k43Eig--~B/aD00MDA7dz02MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/6c24f9e1d809ad15320a801b2524cb1e.cf.webp",
              "width": 600,
              "height": 400,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/hL_YSVPR8V1aa0T3EYsyIg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/6c24f9e1d809ad15320a801b2524cb1e.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "GlobeNewswire",
          "url": "https://www.globenewswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/north-america-heart-pump-device-090400009.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/north-america-heart-pump-device-090400009.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "GNGBF"
            },
            {
              "symbol": "ABT"
            },
            {
              "symbol": "FSNUF"
            },
            {
              "symbol": "LIVN"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]